SCHEMBL21273219

SCHEMBL21273219

Cn1c(C(F)(F)F)nc2c(=O)[nH]cnc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PNP P00491 2/20 0.39
ATAD2 Q6PL18 1/20 0.38
CYP1A2 P05177 2/20 0.38
GLA P06280 1/20 0.38
PDE4A P27815 3/20 0.37
ADORA2A P29274 3/20 0.37
ADORA2B P29275 3/20 0.37
PDE4B Q07343 3/20 0.37
PDE4C Q08493 3/20 0.37
PDE4D Q08499 3/20 0.37
PIK3CD O00329 2/20 0.37
ALPL P05186 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
TMIGD3 P0DMS9 1/20 0.37
ADORA1 P30542 1/20 0.37
CYP2C19 P33261 1/20 0.37
HIF1A Q16665 1/20 0.37
HPRT1 P00492 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867066 0.79 ALDH1A1 (0.44) PARP1ALDH1A1PNPATAD2CYP1A2
SCHEMBL21579656 0.77 ALDH1A1 (0.45) PARP1ALDH1A1PNPATAD2CYP1A2
SCHEMBL14441125 0.77 ALDH1A1 (0.45) PARP1ALDH1A1ATAD2CYP1A2PDE4A
SCHEMBL13202761 0.76 ADORA2A (0.51) ALDH1A1PNPATAD2CYP1A2PDE4A
SCHEMBL23639740 0.72 CYP1A2 (0.41) PARP1ALDH1A1CYP1A2GLAPDE4A
SCHEMBL5429613 0.69 ADORA2A (0.41) PARP1ALDH1A1ADORA2AADORA2BADORA3
SCHEMBL21272945 0.68 PARP1 (0.46) PARP1ALDH1A1ADORA3
SCHEMBL788659 0.68 PIK3CD (0.42) CYP1A2GLAPDE4AADORA2AADORA2B
SCHEMBL5429656 0.68 MEN1 (0.51) PARP1ALDH1A1CYP1A2ADORA2AADORA2B
SCHEMBL1992701 0.67 HPRT1 (0.54) ALDH1A1PNPADORA2AADORA1HPRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4026832-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 Almac Discovery Limited (GB) 2022-07-13 EP disclosed
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 ALMAC DISCOVERY LIMITED (GB) 2020-09-08 US disclosed
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 GENETECH, INC. 2019-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256518-A1 PIPERIDINE DERIVATIVES AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7 USP7, USP5, UBA7 PARP1 719/4885ALDH1A1 1201/4885PNP 2551/4885
US-10766903-B2 Piperidine derivatives as inhibitors of ubiquitin specific protease 7 USP7, USP5, UBA7 PARP1 719/4885ALDH1A1 1201/4885PNP 2551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.